Nickel(II), zinc(II), and cadmium(II) complexes of certain tetraazacycloalkanes (L), [M(L)](ClO4)2, take up CO2 as R2NCO2− to give carbamato complexes, [M(O2CNR2)(L)]+, where L=(7RS,14RS)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane (L1) for M=Ni2+, and L=1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane (L2) for M=Ni2+, Zn2+, and Cd2+. The resulting complexes have been characterized by means of IR, and NMR or electronic spectroscopy. X-Ray analysis of [Ni(O2CN(C2H5)2)(L1)]ClO4 (monoclinic C2/c, a=15.842(3), b=13.675(3), c=13.753(2) Å, β=109.94(1)°) shows that it is a discrete six-coordinate complex with cis-NiO2N4 geometry, and the carbamato ligand is bidentate. Desired carbamato complexes were hardly obtained with [M(L)]2+ containing tetraaza macrocyclic ligand which favors square-planar coordination. All the data indicate that carbamate ions chelate the metals, and thus use of tetraazacycloalkanes which fold readily is essential for this type of CO2 uptake.
No takes yet. Share an insight, caveat, or question.
Ito et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: